In a long-awaited milestone in the gene therapy space, the Food and Drug Administration (FDA) approved two gene therapies to
Continue Reading Gene Therapy Approvals Gain Steam in 2023: FDA Approves First Gene Therapies for Sickle Cell Diseasegene therapy
Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024
Gene therapy is part of a new wave of medicine that approaches disease treatment by addressing the root causes rather…
Continue Reading Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024Gene Therapy Approvals Gain Steam in 2023: Treatments Offer New Hopes for Rare Diseases
After decades of intense scientific research into developing gene editing technologies, and more than a few setbacks, the field has…
Continue Reading Gene Therapy Approvals Gain Steam in 2023: Treatments Offer New Hopes for Rare DiseasesVertex and Mammoth Biosciences Ink $700M Deal for Ultra-Small CRISPR Systems
Vertex Pharmaceuticals and Mammoth Biosciences, a Brisbane, California-based genetic research company, announced a new collaboration for the development of in …
Continue Reading Vertex and Mammoth Biosciences Ink $700M Deal for Ultra-Small CRISPR Systems
Pfizer and Voyager Agree to Develop Neurologic and Cardiovascular Gene Therapies Valued at up to $630 Million
On October 6, 2021, Voyager Therapeutics and Pfizer entered into a license option agreement, which allows Pfizer to exercise options…
Continue Reading Pfizer and Voyager Agree to Develop Neurologic and Cardiovascular Gene Therapies Valued at up to $630 Million
Abbvie and Regenexbio Agree to Develop and Commercialize Eye Disease Gene Therapy
On September 13, 2021, Regenxbio, a Maryland biotech company, and AbbVie announced that they have entered an agreement to develop…
Continue Reading Abbvie and Regenexbio Agree to Develop and Commercialize Eye Disease Gene Therapy
Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development
Earlier this week, Biogen and ViGeneron signed a global collaboration and licensing agreement to develop gene therapies for inherited eye…
Continue Reading Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development